Surgery Partners Inc. reported third quarter 2025 revenue of $716.7 million, a 6.6% increase compared to the prior year period. Same-facility revenues rose by 6.3%. Surgical cases grew by 2.1%, with same-facility cases increasing 3.4%. The company reported a net loss attributable to Surgery Partners Inc. of $22.7 million for the quarter. Adjusted EBITDA increased 6.1% to $136.4 million. As of September 30, 2025, the company held $203.4 million in cash and cash equivalents, with $405.9 million available under its revolving credit facility. Cash flows from operating activities were $83.6 million for the third quarter, up from $65.2 million in the same period of 2024. Year-to-date operating cash flows totaled $170.9 million, compared to $188.7 million in the prior year period. For full year 2025, Surgery Partners expects revenue of $3.28 billion to $3.30 billion and Adjusted EBITDA of $535 million to $540 million.